StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.03 (-7.82%)

Close on Nov 17, 2026Market cap $1.29MP/E –Yield –

Scinai Immunotherapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Scinai Immunotherapeutics's total debt was $382.00K at Dec 31, 2022. For fiscal 2022 it was $382.00K, up 1.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$382.00K+1.9%
FY2021Dec 31, 2021$375.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$382.00K–
Q4 FY2021Dec 31, 2021$375.00K–

More Scinai Immunotherapeutics figures

See a number that looks wrong?